PAP 2023: Corey Ford Discusses Experience in Tackling Reimbursement Challenges at Access PAP 2023

The advantages and challenges associated with structuring a patient assistance program as a non-profit foundation.

Alice Valder Curran outlines the steps manufacturers should take to better prepare for upcoming executive actions on drug pricing and market access.

Doubling down on patient access and support fundamentals will win out over Washington’s next move.

Renier Brentjens, MD, PhD outlines the evolution of the space, while offering ways to boost patient access to these treatments.

As the rising cost of prescription medications in the United States becomes an increasing barrier for millions of people, how can we effectively address and improve patient adherence?

An exploration into how flawed incentives and contractual loopholes between manufacturers and pharmacy benefit managers played their part.